Skip to content

University of Colorado Anschutz

Boston Business Watch reported on University of Colorado Anschutz on October 7, 2026.

What we have reported

  1. October 7, 2026

    Boston Biotech Rezera Says Its Pill Boosts Semaglutide's Anti-Inflammatory Effect

    Rezera reported positive Phase 2 results on October 7, 2026 for ruvonoflast combined with semaglutide in 82 adults with obesity.